## Abstract **__Background__**: Mizoribine (MZR), isolated from culture medium of the mold, is a novel immunosuppressant developed in Japan. It has been used in patients with renal transplantation, lupus nephritis, nephrotic syndrome and rheumatoid arthritis (RA). **__Objectives__**: To review M
β¦ LIBER β¦
Update on the medical treatment of juvenile idiopathic arthritis
β Scribed by Philip J. Hashkes; Ronald M. Laxer
- Book ID
- 107553854
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 167 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1523-3774
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Mizoribine in the treatment of rheumatoi
β
Syuji Takei
π
Article
π
2002
π
John Wiley and Sons
π
English
β 90 KB
Clinical trials for the treatment of sys
β
Thomas J. A. Lehman
π
Article
π
2000
π
Springer
π
English
β 71 KB
Caregiver recall of treatment recommenda
β
Civita, Mirella De ;Feldman, Debbie Ehrmann ;Meshefedjian, Garbis A. ;Dobkin, Pa
π
Article
π
2007
π
John Wiley and Sons
π
English
β 89 KB
π 2 views
## Abstract ## Objective Health care providers in juvenile idiopathic arthritis (JIA) might refer to caregivers' selfβreport of children's treatmentβrelated behaviors to assist in clinical decisions. However, caregivers may believe that they are adhering to treatment even though they have a differ
Leukocytapheresis for the treatment of r
β
Hiroshi Tanaka; Koji Tsugawa; Tohru Nakahata; Koichi Suzuki; Etsuro Ito
π
Article
π
2006
π
Springer
π
English
β 68 KB
Relative ineffectiveness of triamcinolon
β
K. Alsufyani; O. Ortiz-Alvarez; D. A. Cabral; L. B. Tucker; R. E. Petty; P. N. M
π
Article
π
2004
π
John Wiley and Sons
π
English
β 117 KB
π 2 views
Update on the Assessment of Children wit
β
Adam M. Huber
π
Article
π
2010
π
Springer
π
English
β 168 KB